EUVIMEDEUVIMED entdecken
Crossref

Comparative Analysis of Treatment Patterns in DoD Beneficiaries With Malignant Central Nervous System Tumors: A Focus on Care Setting

Aaron J Hill iD, Yvonne L Eaglehouse iD, Sarah Darmon, Heather J Tracy, Brett J Theeler, Kangmin Zhu iD, Craig D Shriver iD, Hong Xue iD

Military Medicine · 2025

DOI: 10.1093/milmed/usae477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Military Medicine, 2025. Verfasst von Aaron J Hill und 7 weiteren Autor:innen. Beteiligte Einrichtung: Murtha Cancer Research Program, Department of Surgery, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bet…. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Henry M. Jackson Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Malignant brain and other central nervous system tumors (MBT) are deadly and disproportionately affect younger men and women in the age range of most active-duty service members. Timely and appropriate treatment is important to both survival and quality of life of patients. Information on treatment factors across direct care (DC) and private sector care (PSC) networks may be important for provider training and staffing for the DoD. The aim of this study was to analyze treatment patterns for patients with MBT within the DoD’s universal access Military Health System (MHS), comparing DC and PSC networks. Materials and Methods The Military Cancer Epidemiology database was used to identify patients 18 years and older who were diagnosed with an MBT between 1999 and 2014 who received primary treatment. Differences in first treatment type and time from diagnosis to initial treatment between DC and PSC were assessed using chi-square and Wilcoxon–Mann–Whitney tests, respectively. Frequency of treatment initiation beyond the 28-day TRICARE Prime access standard for Specialty Care was also compared between care settings using chi-square and Fisher’s exact tests. Then logistic regression models generated odds of treatment initiation beyond 28 days and 95% confidence intervals (CIs) associated with care setting. Kaplan–Meier survival curves and log-rank tests compared survival between DC and PSC.

Results

The study included 857 patients, with n = 540 treated in DC and n = 317 treated in PSC. The proportion of patients receiving each initial treatment type did not differ by care setting (P = .622). Median time from diagnosis to initial treatment (interquartile range) varied significantly between DC at 6 (0 to 25) days and PSC at 12 (0 to 37) days for all treatment types combined (P < .001). For all years combined, treatment was initiated beyond 28 days for 21% of patients using DC compared to 31% of patients using PSC (P = .001). The odds of treatment initiation beyond 28 days for a patient treated in PSC were 1.61 (95% CI, 1.11 to 2.33, P = .012) compared to patients treated in DC when controlling for demographic, military, tumor, and patient variables. Survival did not differ by care setting (P = 1.000).

Conclusions

Based on the available data between 1999 and 2014, care setting was associated with differences in time to initial treatment and odds of treatment initiation beyond 28 days among DoD beneficiaries with MBT receiving care in the MHS. Information on these differences may help inform MHS leadership decisions on the most appropriate location for military provider training and staffing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System NeoplasmsHumansFemaleMaleMiddle AgedUnited StatesAdultMilitary PersonnelAgedUnited States Department of Defense

Autor:innen und Institutionen

  • Murtha Cancer Research Program, Department of Surgery, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20817, USA.
  • Department of Preventive Medicine & Biostatistics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20817, USA.
  • Department of Health Administration and Policy, College of Public Health, George Mason University, Fairfax, VA 22201, USA.
  • The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, USA.
  • Department of Medicine, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20817, USA.
  • Department of Neurology, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20817, USA.

ORCID-Profile: Aaron J Hill, Yvonne L Eaglehouse, Kangmin Zhu, Craig D Shriver, Hong Xue

Förderung

  • Henry M. Jackson Foundation

Zitieren

APA

Hill, A. J., Eaglehouse, Y. L., Darmon, S., Tracy, H. J., Theeler, B. J., Zhu, K., Shriver, C. D., & Xue, H. (2025). Comparative Analysis of Treatment Patterns in DoD Beneficiaries With Malignant Central Nervous System Tumors: A Focus on Care Setting. Military Medicine. https://doi.org/10.1093/milmed/usae477

Vancouver

Hill AJ, Eaglehouse YL, Darmon S, Tracy HJ, Theeler BJ, Zhu K, et al. Comparative Analysis of Treatment Patterns in DoD Beneficiaries With Malignant Central Nervous System Tumors: A Focus on Care Setting. Military Medicine. 2025. doi:10.1093/milmed/usae477

BibTeX
@article{Hill2025,
  author = {Hill, Aaron J and Eaglehouse, Yvonne L and Darmon, Sarah and Tracy, Heather J and Theeler, Brett J and Zhu, Kangmin and Shriver, Craig D and Xue, Hong},
  title = {Comparative Analysis of Treatment Patterns in DoD Beneficiaries With Malignant Central Nervous System Tumors: A Focus on Care Setting},
  journal = {Military Medicine},
  year = {2025},
  doi = {10.1093/milmed/usae477}
}
Kostenlos starten →